Psych drug maker KemPharm to add jobs if FDA OKs new ADHD treatment

The company recently completed a series of transactions to alleviate $93.1 million in debt.

Source: bizjournals.com Health Care:Physician Practices headlines - February 5, 2021 Category: American Health Authors: Alex Soderstrom Source Type: news